Clinical Trial Update: Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of GSK1278863 in subjects with end stage renal disease on peritoneal dialysis completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaemia

Drugs mentioned

• GSK1278863

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED | Results posted: 2019-03-11